ABCZF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
CMVLF
Price
$2.54
Change
-$0.42 (-14.19%)
Updated
May 21 closing price
Ad is loading...

ABCZF vs CMVLF

Header iconABCZF vs CMVLF Comparison
Open Charts ABCZF vs CMVLFBanner chart's image
Abcam
PriceLoading...
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Cellectis Romainville
Price$2.54
Change-$0.42 (-14.19%)
Volume$200
CapitalizationN/A
ABCZF vs CMVLF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABCZF vs. CMVLF commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCZF is a Buy and CMVLF is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ABCZF: $22.25 vs. CMVLF: $2.54)
Brand notoriety: ABCZF and CMVLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCZF: 100% vs. CMVLF: 100%
Market capitalization -- ABCZF: $5.12B vs. CMVLF: $168.21M
ABCZF [@Biotechnology] is valued at $5.12B. CMVLF’s [@Biotechnology] market capitalization is $168.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCZF’s FA Score shows that 1 FA rating(s) are green whileCMVLF’s FA Score has 1 green FA rating(s).

  • ABCZF’s FA Score: 1 green, 4 red.
  • CMVLF’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABCZF and CMVLF are a bad buy in the long-term.

Price Growth

ABCZF (@Biotechnology) experienced а 0.00% price change this week, while CMVLF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ABCZF($5.12B) has a higher market cap than CMVLF($168M). ABCZF YTD gains are higher at: 0.000 vs. CMVLF (-15.050).
ABCZFCMVLFABCZF / CMVLF
Capitalization5.12B168M3,048%
EBITDAN/A-58.52M-
Gain YTD0.000-15.050-
P/E Ratio1770.50N/A-
RevenueN/A29.1M-
Total CashN/A261M-
Total DebtN/A91.5M-
FUNDAMENTALS RATINGS
ABCZF vs CMVLF: Fundamental Ratings
ABCZF
CMVLF
OUTLOOK RATING
1..100
5039
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
8698
PRICE GROWTH RATING
1..100
7071
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMVLF's Valuation (30) in the null industry is significantly better than the same rating for ABCZF (99). This means that CMVLF’s stock grew significantly faster than ABCZF’s over the last 12 months.

ABCZF's Profit vs Risk Rating (68) in the null industry is in the same range as CMVLF (100). This means that ABCZF’s stock grew similarly to CMVLF’s over the last 12 months.

ABCZF's SMR Rating (86) in the null industry is in the same range as CMVLF (98). This means that ABCZF’s stock grew similarly to CMVLF’s over the last 12 months.

ABCZF's Price Growth Rating (70) in the null industry is in the same range as CMVLF (71). This means that ABCZF’s stock grew similarly to CMVLF’s over the last 12 months.

ABCZF's P/E Growth Rating (1) in the null industry is significantly better than the same rating for CMVLF (100). This means that ABCZF’s stock grew significantly faster than CMVLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABCZFCMVLF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
37%
Bullish Trend 2 days ago
34%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
28%
Bullish Trend 2 days ago
35%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LSAK5.110.05
+0.99%
Lesaka Technologies
SNTI5.150.04
+0.78%
Senti Biosciences Inc.
BLDR160.12-0.45
-0.28%
Builders FirstSource
BCSF17.07-0.08
-0.47%
Bain Capital Specialty Finance
RNA32.74-0.65
-1.95%
Avidity Biosciences

ABCZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCZF has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ABCZF jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCZF
1D Price
Change %
ABCZF100%
N/A
IKNA - ABCZF
72%
Closely correlated
+0.62%
ATRA - ABCZF
69%
Closely correlated
-1.52%
CMVLF - ABCZF
62%
Loosely correlated
N/A
CLLS - ABCZF
58%
Loosely correlated
-1.45%
NUVL - ABCZF
52%
Loosely correlated
+0.78%
More

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been closely correlated with CLLS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CMVLF jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
CLLS - CMVLF
78%
Closely correlated
-1.45%
ABCZF - CMVLF
59%
Loosely correlated
N/A
SLN - CMVLF
41%
Loosely correlated
-3.41%
ALDX - CMVLF
39%
Loosely correlated
+5.34%
CLGN - CMVLF
37%
Loosely correlated
+0.45%
More